Fuso Pharmaceutical Industries Stock

Fuso Pharmaceutical Industries Equity 2024

Fuso Pharmaceutical Industries Equity

36.66 B JPY

Ticker

4538.T

ISIN

JP3823600006

In 2024, Fuso Pharmaceutical Industries's equity was 36.66 B JPY, a 6.17% increase from the 34.53 B JPY equity in the previous year.

Fuso Pharmaceutical Industries Aktienanalyse

What does Fuso Pharmaceutical Industries do?

Fuso Pharmaceutical Industries ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Fuso Pharmaceutical Industries's Equity

Fuso Pharmaceutical Industries's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Fuso Pharmaceutical Industries's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Fuso Pharmaceutical Industries's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Fuso Pharmaceutical Industries's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Fuso Pharmaceutical Industries’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Fuso Pharmaceutical Industries stock

What is the equity of Fuso Pharmaceutical Industries this year?

Fuso Pharmaceutical Industries has equity of 36.66 B JPY this year.

What was the equity of Fuso Pharmaceutical Industries compared to the previous year?

The equity of Fuso Pharmaceutical Industries has increased/decreased by 6.17% increased compared to the previous year.

What impact does a high equity have on investors of Fuso Pharmaceutical Industries?

A high equity is advantageous for investors of Fuso Pharmaceutical Industries as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Fuso Pharmaceutical Industries?

A low equity can be a risk for investors of Fuso Pharmaceutical Industries, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Fuso Pharmaceutical Industries affect the company?

An increase in equity of Fuso Pharmaceutical Industries can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Fuso Pharmaceutical Industries affect the company?

A reduction in equity of Fuso Pharmaceutical Industries can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Fuso Pharmaceutical Industries?

Some factors that can affect the equity of Fuso Pharmaceutical Industries include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Fuso Pharmaceutical Industries so important for investors?

The equity of Fuso Pharmaceutical Industries is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Fuso Pharmaceutical Industries take to change the equity?

To change equity, Fuso Pharmaceutical Industries can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Fuso Pharmaceutical Industries pay?

Over the past 12 months, Fuso Pharmaceutical Industries paid a dividend of 75 JPY . This corresponds to a dividend yield of about 3.42 %. For the coming 12 months, Fuso Pharmaceutical Industries is expected to pay a dividend of 75 JPY.

What is the dividend yield of Fuso Pharmaceutical Industries?

The current dividend yield of Fuso Pharmaceutical Industries is 3.42 %.

When does Fuso Pharmaceutical Industries pay dividends?

Fuso Pharmaceutical Industries pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of Fuso Pharmaceutical Industries?

Fuso Pharmaceutical Industries paid dividends every year for the past 20 years.

What is the dividend of Fuso Pharmaceutical Industries?

For the upcoming 12 months, dividends amounting to 75 JPY are expected. This corresponds to a dividend yield of 3.42 %.

In which sector is Fuso Pharmaceutical Industries located?

Fuso Pharmaceutical Industries is assigned to the 'Health' sector.

Wann musste ich die Aktien von Fuso Pharmaceutical Industries kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Fuso Pharmaceutical Industries from 12/1/2024 amounting to 40 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Fuso Pharmaceutical Industries pay the last dividend?

The last dividend was paid out on 12/1/2024.

What was the dividend of Fuso Pharmaceutical Industries in the year 2023?

In the year 2023, Fuso Pharmaceutical Industries distributed 75 JPY as dividends.

In which currency does Fuso Pharmaceutical Industries pay out the dividend?

The dividends of Fuso Pharmaceutical Industries are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Fuso Pharmaceutical Industries

Our stock analysis for Fuso Pharmaceutical Industries Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Fuso Pharmaceutical Industries Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.